KFP
IONS icon

KB Financial Partners’s Ionis Pharmaceuticals IONS Stock Holding History

KB Financial Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34
Closed -$1K – 634
2021
Q4 		$1K Buy
+34
New +$1.07K ﹤0.01% 635
2021
Q3 		– Sell
-4,030
Closed -$161K – 357
2021
Q2 		$161K Buy
4,030
+1,764
+78% +$69.1K 0.06% 175
2021
Q1 		$102K Buy
+2,266
New +$126K 0.04% 203

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

KB Financial Partners's IONS Position: Q1 2022 in Review

KB Financial Partners sold out of Ionis Pharmaceuticals (IONS) in Q1 2022, closing a stake of 34 shares — an estimated $1K sold.

KB Financial Partners first reported a position in IONS in Q1 2021 and held it in 3 quarters. The position peaked at $161K in Q2 2021. 332 funds tracked by Wall St. Rank hold IONS as of Q1 2022.

  • KB Financial Partners reported no remaining Ionis Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • KB Financial Partners sold 34 Ionis Pharmaceuticals shares in Q1 2022, an estimated $1K.
  • KB Financial Partners first reported a position in Ionis Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • KB Financial Partners's Ionis Pharmaceuticals position peaked at $161K in Q2 2021.
  • 332 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2022.

Based on KB Financial Partners's 13F filing for Q1 2022, filed 17 May 2022.